Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma

NCT00003375 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT00003375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma
Lead sponsor
Radiation Therapy Oncology Group
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 1998
Completion date
May 14, 2018
Enrollment
370 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors